Hannah Douglass is a PhD Student at the Centre for Psychedelic Research, Imperial College London, where she is supervised by Dr Robin Carhart-Harris, Dr Meg Spriggs and Dr David Erritzoe. Prior to commencing her PhD she graduated from the University of Leeds with a BSc in Pharmacology and later obtained an MSc in Translational Neuroscience from Imperial College London. During her MSc she analysed previously collected EEG data to identify psilocybin-induced enhancement of neuroplasticity in healthy psychedelic-naïve participants. She was later awarded the President's PhD Scholarship to investigate the feasibility and efficacy of psilocybin as a treatment for anorexia nervosa. Her research interests also include the enhancement of long-term potentiation, cognitive flexibility and interoceptive awareness by psychedelics.